The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma shallow whole-genome sequencing profiling in patients with RASWT metastatic colorectal cancer (mCRC) undergoing first-line anti-EGFR therapy.
 
Valentino Martelli
No Relationships to Disclose
 
Joana Vidal Barrull
No Relationships to Disclose
 
Concepción Fernández-Rodríguez
Speakers' Bureau - AstraZeneca; Merck; Roche
Travel, Accommodations, Expenses - Merck; Palex
 
Joan Gibert
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Ana Moreno
No Relationships to Disclose
 
Aya Louhamane
No Relationships to Disclose
 
Jenniffer Linares-Aceituno
No Relationships to Disclose
 
Pilar Garcia-Alfonso
Consulting or Advisory Role - Amgen; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
Speakers' Bureau - Amgen; BMS; Merck Serono; MSD Oncology; Sanofi; SERVIER
 
David Paez
Consulting or Advisory Role - Amgen; Esteve
Speakers' Bureau - Amgen; MSD; Novartis
Travel, Accommodations, Expenses - Amgen; Ipsen; Lilly; Merck; Sanofi
 
Vicente Alonso
Consulting or Advisory Role - Amgen; Ipsen; Merck; Novartis; Pierre Fabre; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck; Novartis; Sanofi; SERVIER
 
Maria Auxiliadora Gomez Espana
No Relationships to Disclose
 
Cristina Santos
Travel, Accommodations, Expenses - Amgen; Merck KGaA; MSD Oncology
 
Gema Durán
No Relationships to Disclose
 
Elena Elez
Honoraria - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; Janssen; Lilly; Medscape; Merck; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics; RIN Institute Inc.; Roche; Sanofi/Aventis; Seagan; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Cure Teq AG; Janssen; Merck; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics Inc.; RIN Institute Inc.; Roche; Roche; Sanofi; Seagen; SERVIER; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bioncotech (Inst); Biontech Rna Pharmaceuticals GMBH (Inst); Biontech Small Molecules GMBH (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim Spain (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Inc. (Inst); Debiopharm Group (Inst); Genentech (Inst); Gercor (Inst); HalioDx (Inst); Hoffmann-La-Roche Ltd. (Inst); Hutchison MediPharma (Inst); Hutchison MediPharma (Inst); Iovance Biotherapeutics (Inst); Janssen Research & Development (Inst); Janssen-Cilag SA (Inst); MedImmune (Inst); Menarini (Inst); Menarini (Inst); Merck (Inst); Merck Sharp&Dohme de España SA (Inst); Merus NV (Inst); Mirati Therapeutics (Inst); Nouscom SRL. (Inst); Novartis (Inst); Novartis Farmacéutica SA (Inst); Pfizer (Inst); PharmaMar (Inst); Pierre Fabre (Inst); PledPharma (Inst); Redx Pharma (Inst); Roche (Inst); Sanofi (Inst); Scandion Oncology (Inst); Seagen (Inst); SERVIER (Inst); Sotio (Inst); Taiho Pharma USA (Inst); Taiho Pharmaceutical (Inst); WntResearch (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; Janssen; Lilly; Medscape; Merck; Merck Serono; MSD; Novartis; Pfizer; Pierre fabre; Repare Therapeutics; RIN Institute Inc.; Roche; Sanofi; Seagan; SERVIER; Takeda
 
Beatriz Bellosillo Paricio
Consulting or Advisory Role - AstraZeneca; Merck; Novartis; Roche; Thermofisher Scientific Biomarkers
Speakers' Bureau - AstraZeneca; Janssen; Merck; Novartis; Pfizer; Roche; Thermofisher Scientific Biomarkers
Research Funding - AstraZeneca; Roche; Thermofisher Scientific Biomarkers
Patents, Royalties, Other Intellectual Property - Biocartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Josep Tabernero
Stock and Other Ownership Interests - 1TRIALSP; Alentis Therapeutics; Oniria Therapeutics; Pangaea Oncology
Consulting or Advisory Role - Accent Therapeutics; Alentis Therapeutics; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; Lilly; Menarini; Merus; MSD; Novartis; Ono Pharmaceutical; Peptomyc; Pfizer; Pierre Fabre; Quantro Therapeutics; Scandion Oncology; Scorpion Therapeutics; Servier; Sotio; Taiho Pharmaceutical; Takeda Pharmaceuticals International AG; Tolremo
 
Ramon Salazar
Leadership - Sace Medhealth; SaceMedhealth (I)
Consulting or Advisory Role - Genzyme; GlaxoSmithKline; WntResearch
Research Funding - WntResearch
Expert Testimony - Esteve; SERVIER
Travel, Accommodations, Expenses - Esteve
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi
 
Rodrigo Toledo
Research Funding - AstraZeneca; BeiGene; Novartis
 
Clara Montagut
Consulting or Advisory Role - Biocartis; Guardant Health; Merck; Sanofi
Speakers' Bureau - Amgen; Guardant Health; Merck; Roche
Research Funding - Symphogen
Patents, Royalties, Other Intellectual Property - Biocartis (Inst)